INTRODUCTION
============

*Staphylococcus aureus*, the most virulent *Staphylococcus* species, is also the prevalent pathogen isolated from hospitalized patients and the second most common from patients in outpatient settings ([@b14]). Humans are a natural reservoir of *S. aureus*. The emergence of a pathogen community depends on its ability to survive in different environments and to interact successfully with the host. These microorganisms cause a wide range of syndromes, from skin and soft tissue minor infection up to life-threatening pneumonia and toxemy such as toxic shock syndrome. Both methicillin-sensitive and methicillin-resistant strains isolates are persistent colonizers. Rates of staphylococcal colonization are high among patients with diabetes, intravenous drug users, surgical patients and patients with the acquired immunodeficiency syndrome ([@b2], [@b6]).

Even though in the last three decades pharmacological industries have produced a number of new antibiotics, the resistance to these drugs by microorganisms has increased. In general, bacteria have the genetic ability to transmit and acquire resistance to drugs which are utilized as therapeutic agents. New infections can occur in hospitals resulting in high mortality. Such a fact is cause for concern, because of the number of patients in hospitals who have suppressed immunity, and due to new bacterial strains which are multi-resistant ([@b13]).

Methicillin-resistant *Staphylococcus aureus* (MRSA), identified in the early 1960s coincident with the introduction of methicillin, is now one of the most common causes of bacterial nosocomial infections, mainly in intensive care units. Methicillin resistance results from the production of an altered penicillin binding protein which has decreased affinity for most beta-lactam antibiotics ([@b7], [@b24]).

Flavonoids are phenolic substances widely distributed in all vascular plants and increasingly are becoming the subject of medical research. They have been reported to possess many properties as anti-inflammatory ([@b4]), oestrogenic ([@b11]), enzyme inhibition ([@b9]), antimicrobial ([@b10]), antiallergic ([@b8]), antioxidant ([@b23]), vascular ([@b22]) and cytotoxic antitumor ([@b3]) activities, between others. Most of the beneficial health effects of flavonoids are attributed to their ability to inhibit lipid peroxidation, chelate redox-active metals, and attenuate other processes involving reactive oxygen species ([@b12]). Related studies of antimicrobial activity indicate that crude extracts containing flavonoids, triterpenes and steroids have showed significative activity against various strains of *S. aureus* ([@b21]). The combination of antibiotics with different modes of action against bacterial cells is useful for treatment of bacterial infections. Combination effects between flavonoids and antibiotics have also been reported. Thus, Shibata et al. ([@b20]) found that flavone and its derivatives have synergistic action with the ß-lactams, intensified the susceptibility in MRSA and MSSA. Furthermore, the flavonoid synergistic activity against antibiotic resistant bacteria, under low concentration minimizing the possible toxic effects, was reported ([@b1], [@b18], [@b19]).

The aim of the present work was to investigate *in vitro* synergism between several chalcones substituted in combination with oxacillin, antibiotic used conventionally against *S. aureus* 43 300 (MRSA) which is resistant to it. Kinetic turbidimetric method developed earlier was employed ([@b15]).

MATERIALS AND METHODS
=====================

Compounds
---------

Oxacillin, sodium salt monohydrate (Sigma-Aldrich); 2´,3-dihydroxychalcone ([@b1]), 2´,4-dihydroxychalcone ([@b2]), 2´,4´-dihydroxychalcone ([@b3]) and 2´,4´,3-trihydroxychalcone ([@b4]) were all synthesized in our laboratory by Claisen-Schmidt condensation and identified by chromatographic and spectroscopic techniques (TLC, UV-Vis, IR, NMR) ([@b5]). In addition, 2´,4´-dihydroxy-3´-methoxychalcone ([@b5]), a natural compound isolated from *Zuccagnia punctata* Cav., a native plant to San Luis (Argentina) ([@b17]) was assayed. [Figure 1](#fig1){ref-type="fig"} illustrates the compound structures. Oxacillin and different chalcones solutions were prepared in absolute ethanol and diluted for antimicrobial assays.

![Structure of compounds: 1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 2´,4´,3- trihydroxychalcone; 5: 2´,4´-dihydroxy-3´-methoxychalcone.](bjm-42-470-g001){#fig1}

Bacterial strains
-----------------

*Staphylococcus aureus* ATCC 43 300 (MRSA) strain (purchased from American Type Culture Collection), maintained by successive subcultures in trypticase soy agar BBL (Becton Dickinson) at 4°C and by lyophilization, was used.

Cultura media
-------------

Broth and agar nutritive and broth and agar Müller-Hinton (Oxoid) were used.

Kinetic-turbidimetric assays
----------------------------

In order to determine quantitatively the sensitivity of *S. aureus* to oxacillin and its increase when oxacillin is used in combination with several chalcones, a previously developed kinetic-turbidimetric method was employed ([@b15]).

A 24 h culture of *S. aureus* ATCC 43 300 in agar slant was transferred to 30 mL of Müller-Hinton broth and incubated at 35°C for 18 h, with permanent stirring, in order to be used as inoculum. Kinetic experiments of microbial growth were performed in Erlenmeyer flasks containing 100 mL of Müller-Hinton broth with addition of increasing concentrations of antibiotic oxacillin and 2 mL of previously prepared inoculum. Subsequently, Erlenmeyer flasks were incubated in a Rosi 1000 culture chamber (35°C, 180 rpm). Aliquots were extracted at 20 min intervals for 5 h and the transmittances were read at 720 nm. A flask without antibiotic was used as control. This first experiment enabled us to choose the optimal oxacillin concentration to be used in the next trials (6 µg.mL^-1^).

For synergism determination, similar experiments in presence of chalcone in increasing concentrations, alone or in combination with oxacillin, were performed.

In the following equation:
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the transmittance (T) values at 720 nm were related to the number CFU/mL (N~t~) ([@b15]).

All trials were conducted in triplicate and standard deviations of the specific growth rate, were in all cases lower than 0.001.

RESULTS AND DISCUSSION
======================

The number of CFU/mL at different times was obtained by the turbidimetric kinetic method (Eq. 1). The microbial growth can be expressed by the equation:

ln

N

t

=

ln

N

o

\+

μ

.

t

where t is time in min, N~o~ is CFU/mL at t = 0, N~t~ is CFU/mL at t = t and µ is specific growth rate (in min^-1^).

Growth rates values in media with increasing chalcone concentration and their combinations with oxacillin constant concentration were obtained from the exponential phase of ln Nt vs. t plots.

[Table 1](#tbl1){ref-type="table"} exhibits the specific growth rates of *S. aureus* obtained in presence of chalcones isolated and chalcones -oxacillin combinations with the respective MIC values.

###### 

Specific growth rates and minimal inhibitory concentration for all systems assayed against a methicillin-resistant *Staphylococcus aureus* strain.

  Chalcone   Concentration 5.00 (μg.mL^-1^)   MIC μg.mL^-1^                                            
  ---------- -------------------------------- --------------- --------- --------- --------- ---------- ------
  1          µ (isolated)                     0.0465          0.0380    0.0158    0.00130   0          15.8
             µ (comb)                         0.0465          0.0231    0.00616   0         0          11.2
  2          µ (isolated)                     0.0453          0.0389    0.0350    0.0314    0.0312     45.0
             µ (comb)                         0.0453          0.0150    0.0115    0.0112    0.00653    22.4
             µ (isolated)                     0.0476          0.0373    0.0247    0.00425   0.000400   20.1
  3          µ (comb)                         0.0476          0.0296    0.00928   0.00343   0          15.3
  4          µ (isolated)                     0.0459          0.0386    0.0314    0.0254    0.0131     30.8
             µ (comb)                         0.0459          0.0279    0.0197    0.0157    0.00719    22.5
  5          µ (isolated)                     0.0464          0.0391    0.0348    0.0292    0.0244     42.5
             µ (comb)                         0.0464          0.00988   0.00866   0.00818   0.00766    ∞

1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 2´,4´,3- trihydroxychalcone; 5: 2´,4´-dihydroxy-3´-methoxychalcone. MIC: minimal inhibitory concentration.

The specific growth rate values decreasing when the experiment was made in presence of oxacillin constant concentration. This fact is observed in [Table 1](#tbl1){ref-type="table"} for all assayed combinations. The results were satisfactory, except for 2´,4´-dihydroxy-3´-methoxychalcone -- oxacillin.

They are in accordance with bacteriostatic inhibition mechanism previously proposed ([@b15]). In the same, the exponential growth law of microorganisms and the possible adsorption of substances on the cell wall were considered, resulting in the reduction or cancellation of some vital function:
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The growth rate of bacteria by this mechanism is expressed as:
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Comparing this relationship with the exponential growth law dN/dt =μ.N, it is inferred that:
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where µ~T~: specific growth rate without drug (min^-1^) (control), k~I~: specific inhibition rate (mL.µg^-1^.min^-1^) and C: drug concentration (µg.mL^-1^). The minimal inhibhitory concentration (MIC) was calculated by extrapolation at µ = 0 from the graphical representation of equation 3.

For 2´,4´-dihydroxy-3´-methoxychalcone -- oxacillin combination, antagonist is observed, probably due to the strong complex formation between both molecules. This fact provokes a decrease of the chalcone bacteriostatic activity.

To facilitate comparison of the inhibitory action between structurally related substances such as chalcones and their combinations with conventional antibiotic oxacillin, should be determined the percentual bacteriostatic efficiency of a drug (PBE) ([@b16]), in the form:

PBE

=100/
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where MIC: minimum inhibitory concentration (µg.mL^-1^) and 100: percentage arbitrary numerical factor. Evaluating chalcones PBE tested and comparing with the PBE of these chalcones with oxacillin, can be established that combinations PBE are higher, demonstrating synergism for all of them, except for 2´,4´,dihydroxy-4´-methoxychalcone -- oxacillin combination ([Table 2](#tbl2){ref-type="table"}).

###### 

Minimal inhibitory concentration and percentual bacteriostatic efficiency of isolated chalcones and of chalcones-oxacillin combinations against a methicillin-resistant *Staphylococcus aureus* strain.

  Chalcone   MIC (comb)   PBE (isolated)   PBE(comb)   
  ---------- ------------ ---------------- ----------- ---------
  1          11.2         6.33             \<          8.93
  2          22.4         2.22             \<\<        4.46
  3          15.3         4.97             \<\<        6.53
  4          22.5         3.25             \<          4.44
  5          73.9         2.35             \>\>\>      **≈** 0

1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 2´,4´,3- trihydroxychalcone; 5: 2´,4´-dihydroxy-3 ´-methoxychalcone. MIC: minimal inhibitory concentration.

Chalcones activity against methicillin-resistant *Staphylococcus aureus* (MRSA) was detected by kinetic-turbidimetric method. This inhibition was observed with the isolated chalcones and with their combinations with oxacillin, an ineffective antibiotic. The chalcones -- oxacillin combinations showed an interesting synergic action.

Due to the growing problem of microbial resistant, the outlook for the use of antimicrobial drugs is uncertain. Consequently, the development of researches which seek to increase antibacterial activity and to characterize the interaction mechanism with antibiotics woud be desirable.

Thus, the synergistic effect between chalcones and oxacillin is an important way that could lead to the development of new combination antibiotics against MRSA infections.
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